American College of Cardiology Acquires MedAxiom

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Irrimax Receives FDA Clearance for Irrisept

"This new clearance from the FDA further solidifies Irrisept as the market leader in wound irrigation," said Mark Alvarez, CEO of Irrimax.

February 4, 2019: Today the American College of Cardiology Foundation announced they have acquired MedAxiom, a cardiovascular membership, services and consulting firm, adding the company’s recognized leadership in cardiovascular operations, performance improvement, and business acumen to ACC’s world class science, education, registry, quality improvement and advocacy work.

Through this acquisition, the ACC will expand its offerings as the professional home for the entire cardiovascular team to include services and education in non-clinical domains such as interpersonal and organizational leadership, strategic design, operational and performance management, and improvement and technological infrastructure.

“The expansion of advanced technology and the renewed focus on value are radically remaking what it means to be a good clinician in the 21 Century,” said ACC CEO Tim Attebery, DSc, MBA, FACHE. “We must embrace these changes and ensure that cardiovascular care team members are empowered to thrive in this new world. By welcoming MedAxiom into the ACC family, clinicians, practices, health systems and hospitals can take advantage of the strengths and expertise of both groups to optimize cardiovascular care and patient outcomes.”

ACC is committed to maintaining the entrepreneurial and nimble spirit that has been a hallmark of MedAxiom’s success. MedAxiom will continue to operate as a wholly-owned, but separately incorporated, for-profit enterprise and will continue its current operations from its headquarters in Florida.

Addressing the increasingly complicated business and financial aspects of medicine that extend beyond clinical patient care are vital in today’s health care environment,” said Pat White, MedAxiom president. “MedAxiom is excited to join the ACC Foundation and focus on transforming cardiovascular care, together.”

Attebery will serve as the CEO of MedAxiom in addition to his role at ACC. To ensure continuity, Jennifer Linville, current MedAxiom CEO, will serve as a valuable consultant to the CEO, while Pat White, current MedAxiom president, will serve as a senior advisor.



Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.